Literature DB >> 9414176

Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells.

N Ahmad1, D K Feyes, A L Nieminen, R Agarwal, H Mukhtar.   

Abstract

BACKGROUND AND
PURPOSE: The polyphenolic compounds present in green tea show cancer chemopreventive effects in many animal tumor models. Epidemiologic studies have also suggested that green tea consumption might be effective in the prevention of certain human cancers. We investigated the effect of green tea polyphenols and the major constituent, epigallocatechin-3-gallate, on the induction of apoptosis (programmed cell death) and regulation of cell cycle in human and mouse carcinoma cells.
METHODS: Human epidermoid carcinoma cells (cell line A431), human carcinoma keratinocyte (cell line HaCaT), human prostate carcinoma cells (cell line DU145), mouse lymphoma cells (cell line L5178Y), and normal human epidermal keratinocytes (NHEKs) were used. Apoptosis was assessed by 1) the formation of internucleosomal DNA fragments by agarose gel electrophoresis, 2) confocal microscopy, and 3) flow cytometry after tagging the DNA fragments by fluorescence label. The distribution of cells in different phases of the cell cycle was analyzed by flow cytometry.
RESULTS: Treatment of A431 cells with green tea polyphenols and its components, epigallocatechin-3-gallate, epigallocatechin, and epicatechin-3-gallate, resulted in the formation of internucleosomal DNA fragments, characteristic of apoptosis. Treatment with epigallocatechin-3-gallate also resulted in apoptosis in HaCaT, L5178Y, and DU145 cells, but not in NHEK. Confocal microscopy and flow cytometry confirmed the findings. The DNA cell cycle analysis showed that in A431 cells, epigallocatechin-3-gallate treatment resulted in arrest in the G0-G1 phase of the cell cycle and a dose-dependent apoptosis.
CONCLUSIONS: Green tea may protect against cancer by causing cell cycle arrest and inducing apoptosis. It needs to be evaluated in human trials.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9414176     DOI: 10.1093/jnci/89.24.1881

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  135 in total

Review 1.  Nanochemoprevention: sustained release of bioactive food components for cancer prevention.

Authors:  Imtiaz A Siddiqui; Vaqar M Adhami; Nihal Ahmad; Hasan Mukhtar
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

2.  Epigallocatechin-3-gallate (EGCG) protects against chromate-induced toxicity in vitro.

Authors:  Fen Wu; Hong Sun; Thomas Kluz; Hailey A Clancy; Kathrin Kiok; Max Costa
Journal:  Toxicol Appl Pharmacol       Date:  2011-11-04       Impact factor: 4.219

3.  Epigallocatechin-3-gallate regulates cell growth, cell cycle and phosphorylated nuclear factor-κB in human dermal fibroblasts.

Authors:  Dong-wook Han; Mi Hee Lee; Hak Hee Kim; Suong-hyu Hyon; Jong-chul Park
Journal:  Acta Pharmacol Sin       Date:  2011-04-25       Impact factor: 6.150

4.  Epigenetic reactivation of p21CIP1/WAF1 and KLOTHO by a combination of bioactive dietary supplements is partially ERα-dependent in ERα-negative human breast cancer cells.

Authors:  Sonam Sinha; Samriddhi Shukla; Sajid Khan; Trygve O Tollefsbol; Syed M Meeran
Journal:  Mol Cell Endocrinol       Date:  2015-02-25       Impact factor: 4.102

5.  Anti-cancer activities of tea epigallocatechin-3-gallate in breast cancer patients under radiotherapy.

Authors:  G Zhang; Y Wang; Y Zhang; X Wan; J Li; K Liu; F Wang; K Liu; Q Liu; C Yang; P Yu; Y Huang; S Wang; P Jiang; Z Qu; J Luan; H Duan; L Zhang; A Hou; S Jin; T-C Hsieh; E Wu
Journal:  Curr Mol Med       Date:  2012-02       Impact factor: 2.222

6.  Growth inhibition and apoptosis-induced effect on human cancer cells of toosendanin, a triterpenoid derivative from chinese traditional medicine.

Authors:  Bin Zhang; Zhong-Feng Wang; Mian-Zhi Tang; Yu-Liang Shi
Journal:  Invest New Drugs       Date:  2005-12       Impact factor: 3.850

7.  Curcumin suppresses proliferation of colon cancer cells by targeting CDK2.

Authors:  Tae-Gyu Lim; Sung-Young Lee; Zunnan Huang; Do Young Lim; Hanyong Chen; Sung Keun Jung; Ann M Bode; Ki Won Lee; Zigang Dong
Journal:  Cancer Prev Res (Phila)       Date:  2014-02-18

Review 8.  Curcumin, a multi-functional chemopreventive agent, blocks growth of colon cancer cells by targeting beta-catenin-mediated transactivation and cell-cell adhesion pathways.

Authors:  Satya Narayan
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

Review 9.  Green tea polyphenols for prostate cancer chemoprevention: a translational perspective.

Authors:  J J Johnson; H H Bailey; H Mukhtar
Journal:  Phytomedicine       Date:  2010-01       Impact factor: 5.340

10.  Oxidation-triggered c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3-gallate (EGCG): a distinct pathway from those of chemically induced and receptor-mediated apoptosis.

Authors:  Koichi Saeki; Norihiko Kobayashi; Yuko Inazawa; Hong Zhang; Hideki Nishitoh; Hidenori Ichijo; Kumiko Saeki; Mamoru Isemura; Akira Yuo
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.